EVO ICL in Busan, Korea: Complete Patient Guide
EVO ICL in Busan, Korea: Complete Patient Guide
EVO ICL is an implantable lens option for people who want to correct myopia without removing corneal tissue. It has become an important alternative to laser vision correction for selected patients, particularly those with higher prescriptions or corneal characteristics that may make LASIK or SMILE Pro less suitable.
For international patients considering EVO ICL in Busan, Korea, understanding the procedure before traveling is important. ICL is not simply another type of laser eye surgery. It involves placing a lens inside the eye, so patient selection, eye measurements, lens sizing, surgical planning, and postoperative monitoring all matter.
The EVO ICL family is designed to correct myopia, while EVO TICL is available for selected patients with myopic astigmatism. The specific lens and prescription range depend on the applicable product indication and the patient's eye anatomy.
This guide explains how EVO ICL works, who may be a candidate, what testing is required, how the procedure compares with LASIK and SMILE Pro, what recovery may involve, and what international patients should consider when planning treatment in Busan.
What Is EVO ICL?
How EVO ICL Works
EVO ICL stands for EVO Implantable Collamer Lens. It is a phakic intraocular lens, meaning that it is implanted inside the eye while the natural crystalline lens remains in place.
The lens is positioned in the posterior chamber between the iris and the natural lens. Rather than reshaping the cornea, the ICL changes the way light is focused onto the retina.
This makes the procedure fundamentally different from LASIK, LASEK, and SMILE Pro, which correct refractive errors by modifying corneal tissue.
What Is the EVO+ Version?
EVO+ is a newer version within the EVO ICL family with a larger optical zone than earlier designs.
The larger optical area is intended to accommodate a broader range of pupil sizes and may help address some visual-quality concerns. However, no lens design can guarantee that every patient will experience identical night vision or freedom from visual symptoms.
Patients should discuss the specific lens model available to them with their ophthalmologist rather than assuming that every ICL is identical.
Why Is EVO ICL Different From LASIK?
No Intentional Corneal Tissue Removal
The most obvious difference is how the two procedures correct vision.
LASIK reshapes the cornea with an excimer laser. SMILE Pro removes a corneal lenticule through a small incision. EVO ICL instead uses an implanted lens.
For patients with relatively thin corneas or high prescriptions, this distinction can be particularly important.
A patient who is not suitable for laser vision correction because of corneal characteristics may still be evaluated for ICL. However, ICL has its own anatomical requirements and is not automatically suitable simply because LASIK is unsuitable.
The Natural Lens Remains
EVO ICL does not involve removing the natural crystalline lens.
This differentiates it from cataract surgery and refractive lens exchange.
The natural lens remains inside the eye, while the implanted ICL provides the additional optical correction needed for myopia.
Who May Be a Candidate for EVO ICL?
Patients With Moderate to High Myopia
EVO ICL is particularly relevant for selected patients with moderate to high myopia.
Current U.S. FDA labeling specifies particular prescription ranges, age requirements, anterior chamber depth, endothelial cell requirements, and refractive stability criteria.
The exact criteria used for treatment in Korea can depend on the lens model, local regulatory requirements, and clinical judgment.
Patients With Thin Corneas
Thin corneas are one reason some patients explore ICL.
Because EVO ICL does not require central corneal tissue removal, it can be considered for certain patients who may not be suitable for laser procedures because of corneal thickness or other corneal parameters.
However, thin corneas alone do not establish candidacy.
The ophthalmologist still needs to evaluate the internal anatomy of the eye, including anterior chamber depth and endothelial cell health.
Patients With Stable Prescriptions
Stable refraction is an important part of ICL planning.
Current FDA labeling for EVO ICL includes a requirement for a stable refractive history within 0.5 diopters for one year before implantation.
Your ophthalmologist may review previous prescriptions and perform multiple measurements when necessary.
Who May Not Be Suitable for EVO ICL?
Important Anatomical Requirements
Not everyone with myopia can receive EVO ICL.
The eye needs to have sufficient space for the implant and appropriate internal anatomy.
Current FDA information identifies several conditions that can make EVO ICL unsuitable, including an insufficient anterior chamber, an anterior chamber angle below the specified threshold, inadequate endothelial cell density, and moderate to severe glaucoma.
Other Eye Conditions Matter
Your ophthalmologist may also consider:
- Previous eye surgery
- Eye inflammation
- Cataract
- Retinal conditions
- Elevated eye pressure
- Corneal disease
- Unstable refraction
- Other conditions affecting ocular health
A detailed medical and eye history is therefore an essential part of the consultation.
What Tests Are Needed Before EVO ICL?
Anterior Chamber Depth
Anterior chamber depth is one of the most important measurements for ICL surgery.
It describes the distance within the front portion of the eye and helps determine whether there is adequate space for the implant.
For the EVO ICL indication described in current FDA labeling, the anterior chamber depth must be at least 3.00 mm when measured from the corneal endothelium to the anterior surface of the natural lens.
Your ophthalmologist will use the applicable criteria for the specific lens and treatment setting.
Endothelial Cell Count
The corneal endothelium consists of a single layer of cells that helps maintain corneal clarity.
Because an ICL remains inside the eye, endothelial health is an important part of long-term safety assessment.
The FDA recommends measuring endothelial cell counts during the preoperative evaluation.
Corneal Imaging
Even though EVO ICL does not remove corneal tissue, detailed corneal measurements are still useful.
Testing may include:
- Corneal topography
- Corneal tomography
- Pachymetry
- Corneal curvature measurements
- Anterior segment imaging
- Pupil measurements
These tests can help identify conditions that could affect the choice of refractive procedure.
Retinal Examination
High myopia can be associated with structural changes in the retina.
For this reason, a dilated retinal examination may be particularly important for patients with stronger prescriptions.
If a retinal concern is identified, your ophthalmologist may recommend additional evaluation or treatment before elective refractive surgery.
What Happens During EVO ICL Surgery?
Before the Procedure
The surgical plan begins with precise measurements.
The ophthalmologist needs to determine the appropriate lens specifications and ensure that the selected ICL is suitable for your eye.
Your doctor may also review your medications, allergies, previous eye conditions, contact lens use, and previous surgery. The FDA recommends a complete medical and ocular history as part of the evaluation.
During Surgery
EVO ICL is inserted through a small incision and positioned inside the eye.
The lens is placed behind the iris and in front of the natural lens.
The exact surgical technique and anesthesia approach depend on the surgeon and clinical circumstances.
The procedure itself may be relatively brief, but the preparation, measurements, and postoperative monitoring are equally important parts of the treatment.
After the Lens Is Positioned
The ophthalmologist checks the position of the lens and evaluates the eye before you leave.
Postoperative medication and instructions will depend on the clinic's protocol.
Follow-up is important because the surgeon needs to monitor healing, eye pressure, inflammation, and the position of the implant.
What Is Recovery Like After EVO ICL?
Early Recovery
Many patients experience noticeable visual improvement relatively soon after ICL surgery, but recovery varies.
Temporary symptoms may include:
- Blurred or fluctuating vision
- Light sensitivity
- Mild discomfort
- Redness
- Dryness
- Glare or halos
Not every patient experiences these symptoms, and their duration can vary.
Your surgeon will provide specific instructions regarding eye drops, physical activity, eye protection, swimming, and other activities.
Follow-Up Appointments
Follow-up appointments are particularly important after intraocular surgery.
Your ophthalmologist may evaluate:
- Visual acuity
- Eye pressure
- Lens position
- Inflammation
- Corneal health
- Overall healing
International patients should understand the recommended follow-up schedule before arranging their return flight.
What Are the Benefits of EVO ICL?
Preserves Corneal Tissue
One potential benefit of EVO ICL is that it corrects refractive error without intentionally removing central corneal tissue.
This can be particularly relevant for selected patients with thin corneas or higher prescriptions.
Suitable for Selected High Prescriptions
EVO ICL is available for specific levels of myopia, including higher prescriptions depending on the lens indication.
This is one reason ICL is frequently considered by patients who have been told that they are not suitable candidates for certain laser procedures.
The Lens Can Be Removed if Medically Necessary
An ICL is not intended to be casually removed, but it can potentially be repositioned, exchanged, or removed when medically necessary.
This is different from corneal tissue removed during laser surgery, which cannot simply be restored.
Patients should not interpret this as meaning that ICL is completely reversible or risk-free.
What Are the Risks and Limitations?
ICL Is Intraocular Surgery
One of the most important considerations is that EVO ICL involves surgery inside the eye.
Potential complications can include:
- Increased or decreased eye pressure
- Inflammation
- Infection
- Cataract formation
- Endothelial cell loss
- Lens rotation or displacement
- Visual disturbances
- Residual refractive error
- Need for lens repositioning, exchange, or removal
The actual risk depends on patient selection, surgical technique, lens characteristics, and individual anatomy.
Halos and Glare
Some patients may notice halos, glare, or other visual symptoms after ICL.
The EVO+ design has a larger optical zone than earlier lens designs, but individual results vary.
Patients with larger pupils or specific optical characteristics should discuss night-vision expectations during their consultation.
EVO ICL vs SMILE Pro
Quick Comparison
FeatureEVO ICLSMILE ProMain approachImplantable lensCorneal laser treatmentCorneal tissue removedNoYesNatural lens retainedYesYesIntraocular surgeryYesNoLASIK-style flapNoNoThin corneasMay be suitable for selected patientsMay limit candidacyHigh myopiaSuitable for selected patientsDepends on corneal anatomyAstigmatismToric ICL available for selected casesSelected astigmatism can be treatedImplant remains in eyeYesNoMain candidacy concernInternal eye anatomyCorneal anatomy
Which One Is Better?
Neither is universally better.
EVO ICL may be attractive for patients with high prescriptions or corneal characteristics that make laser treatment less suitable.
SMILE Pro may be attractive for patients with appropriate corneal anatomy who prefer a laser-based procedure and do not want an intraocular implant.
A comprehensive examination should determine which options are medically appropriate.
EVO ICL vs LASIK
Key Differences
LASIK creates a corneal flap and reshapes the underlying corneal tissue.
EVO ICL does not reshape the cornea. Instead, it adds an optical lens inside the eye.
This can make ICL an option worth considering for some patients who have high myopia or corneal measurements that make LASIK less suitable.
However, LASIK does not involve entering the inside of the eye, so the two procedures have different risk profiles.
What About Toric EVO ICL?
ICL for Myopia and Astigmatism
Patients who have myopia combined with astigmatism may be evaluated for a toric ICL.
The toric design is intended to correct both components of the refractive error.
Not everyone with astigmatism will qualify. The amount and type of astigmatism, eye anatomy, lens availability, and other measurements all need to be considered.
How Much Does EVO ICL Cost in Busan?
Factors That Affect Cost
The total cost of EVO ICL treatment can vary depending on:
- Lens model
- Toric or non-toric lens
- Diagnostic testing
- Surgeon and facility fees
- Medication
- Follow-up care
- Whether one or both eyes are treated
- International patient services
Patients should request a current, itemized quotation after the eye examination.
Avoid choosing a clinic solely because of a low advertised price. For an intraocular procedure, diagnostic quality, surgeon experience, appropriate lens sizing, and postoperative care are important considerations.
Why Consider EVO ICL in Busan, Korea?
Busan as a Medical Tourism Destination
Busan has a substantial medical infrastructure and is increasingly accessible to international patients.
The official website of Busan Vision Clinic describes its Busan facility as an ophthalmology center offering EVO ICL, SMILE Pro, LASIK, cataract care, dry-eye treatment, and English-language support for international patients.
Patients should still evaluate the individual medical team and treatment plan rather than assuming that every clinic offers the same level of experience or technology.
Choosing a Clinic for ICL
When comparing ICL clinics in Busan, consider:
- Comprehensive preoperative testing
- Accurate lens sizing
- Experience with ICL procedures
- Availability of toric ICL when appropriate
- Explanation of alternatives
- Transparent pricing
- Postoperative monitoring
- International patient communication
- Emergency or complication-management arrangements
These factors can be more meaningful than promotional claims about being the "best" clinic.
What Should International Patients Know?
Plan the Medical Schedule First
If you are traveling to Busan specifically for EVO ICL, do not organize your trip around a single fixed surgery date without allowing time for examination.
A typical medical travel plan may include:
- Initial consultation
- Detailed diagnostic testing
- Confirmation of candidacy
- Lens planning
- Surgery
- Early postoperative assessment
- Follow-up before departure
The exact timeline varies according to the patient's circumstances and clinic protocol.
Bring Your Previous Eye Records
International patients should consider bringing:
- Recent glasses prescriptions
- Contact lens prescriptions
- Previous eye examination reports
- Previous eye-surgery records
- Retinal examination results
- Current medication information
If you wear contact lenses, ask the clinic how long you should stop wearing them before diagnostic testing. Contact lenses can affect certain measurements, and the FDA notes that discontinuation may be required before examination.
Arrange Follow-Up Care Before Flying Home
Before treatment, ask the clinic how long you should remain in Busan and what follow-up examinations are expected.
It is also useful to know where you can receive ophthalmic care after returning home if an unexpected concern develops.
A good medical tourism plan should include both the procedure and postoperative care.
Questions to Ask Before EVO ICL Surgery
Important Questions for Your Consultation
Consider asking:
- Am I a suitable candidate for EVO ICL?
- What is my exact prescription?
- Is my prescription stable?
- What is my anterior chamber depth?
- Is my endothelial cell count appropriate?
- Is my retina healthy?
- Would SMILE Pro or LASIK be a better option?
- Do I need toric ICL?
- Which EVO ICL model is being recommended?
- What are my individual risks?
- How long should I remain in Busan?
- What follow-up will I need after returning home?
- What is included in the treatment price?
These questions can help you make a decision based on your own eye health rather than general online claims.
Conclusion
EVO ICL is an important vision-correction option for selected patients with myopia, particularly those who may not be ideal candidates for corneal laser procedures.
Because EVO ICL does not intentionally remove corneal tissue, it may be considered for some patients with thin corneas or higher prescriptions. But thin corneas or high myopia alone do not guarantee candidacy.
A proper evaluation should include measurements such as anterior chamber depth, endothelial cell density, prescription stability, corneal characteristics, eye pressure, and overall ocular health. The FDA specifically emphasizes detailed eye examinations and anatomical requirements before EVO ICL surgery.
For international patients considering EVO ICL in Busan, Korea, the safest approach is to plan enough time for diagnostic testing, treatment, and follow-up.
The goal should not simply be to find an advanced lens or a convenient surgery date. It should be to determine whether EVO ICL is appropriate for your eyes and whether the expected benefits justify the potential risks.
FAQs About EVO ICL in Busan, Korea
1. What is EVO ICL?
EVO ICL is an implantable phakic lens designed to correct selected levels of myopia. It is placed inside the eye while the natural crystalline lens remains in place.
2. Is EVO ICL suitable for high myopia?
It can be suitable for selected patients with high myopia. The exact prescription range depends on the lens model and applicable regulatory indication, as well as the patient's eye anatomy.
3. Can people with thin corneas have EVO ICL?
Potentially. Because EVO ICL does not require central corneal tissue removal, it may be considered for selected patients with thin corneas. However, anterior chamber depth, endothelial cell density, and overall eye health must also be appropriate.
4. Is EVO ICL better than SMILE Pro?
Neither procedure is universally better. EVO ICL and SMILE Pro use fundamentally different approaches, so the better option depends on the patient's prescription, corneal anatomy, internal eye anatomy, and visual goals.
5. Does EVO ICL correct astigmatism?
A toric version of ICL can correct selected combinations of myopia and astigmatism. Eligibility depends on the prescription and eye measurements.
6. Is EVO ICL permanent?
The lens is designed for long-term implantation, but it can potentially be repositioned, exchanged, or removed when medically necessary. This does not mean the procedure is completely reversible or risk-free.
7. Does EVO ICL cause halos at night?
Some patients can experience halos, glare, or other visual disturbances. The EVO+ design has a larger optical zone than earlier designs, but individual night-vision outcomes vary.
8. What tests are needed before EVO ICL?
Testing may include refraction, corneal imaging, anterior chamber depth, endothelial cell density, eye pressure, pupil assessment, and retinal examination. The FDA specifically recommends measuring anterior chamber depth and endothelial cell counts before phakic lens surgery.
9. How long should international patients stay in Busan after EVO ICL?
The appropriate stay depends on the patient's recovery and the clinic's follow-up protocol. International patients should confirm the recommended postoperative schedule before booking their return flight.
10. Is EVO ICL available in Busan, Korea?
EVO ICL is offered by ophthalmic providers in Busan, and the official Busan Vision Clinic website lists EVO ICL among its vision-correction services. Patients should undergo a comprehensive examination to determine whether they are suitable.
